REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmagal Cz, S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Pharmagal Cz, S.R.O. Profile Updated: October 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharmagal Cz, S.R.O. is an enterprise based in Czech Republic. Its main office is in Nove Mesto na Morave. The company operates in the Pharmacies and Drug Stores sector. It was established on November 14, 1997. It currently has a total number of 6 - 9 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 0.17% in 2024. Its’ total assets recorded a negative growth of 1.49%. The net profit margin of Pharmagal Cz, S.R.O. increased by 0.84% in 2024.

Headquarters
Petrovicka 857
Nove Mesto na Morave; Kraj Vysocina; Postal Code: 59231

Contact Details: Purchase the Pharmagal Cz, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmagal Cz, S.R.O. report to view the information.
Registered Capital:
Purchase the Pharmagal Cz, S.R.O. report to view the information.
Financial Auditors:
Purchase the Pharmagal Cz, S.R.O. report to view the information.
Incorporation Date:
November 14, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmagal Cz, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-0.17%
Total operating revenue
0.55%
Operating profit (EBIT)
41.92%
EBITDA
35.09%
Net Profit (Loss) for the Period
41.58%
Total assets
-1.49%
Total equity
-22.75%
Operating Profit Margin (ROS)
0.84%
Net Profit Margin
0.84%
Return on Equity (ROE)
9.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?